Marta G. Zanchi

About

Dr Marta G. Zanchi, a former director of Stanford Biodesign’s Digital Health initiatives and medical technology executive, and Marc Subirats, an accomplished entrepreneur whose telemedicine company Advance Medical was acquired by Teladoc Health, bring relevant hands-on experience to their roles as General Partners. “This fund is the next natural chapter of our story, building on a proven strategy and team,” said Subirats. Like previous funds, Fund III will focus on three critical healthtech areas: [...] “Healthcare is at an inflection point. We see extraordinary opportunities for innovation to break down inefficiencies, increase access, and improve outcomes. Fund III solidifies our commitment to finding and supporting the boldest minds tackling healthcare’s most urgent challenges,” said Dr Marta G. Zanchi, Founder and Managing Director at Nina Capital. “Our mission is clear: to find and support the founders who are solving timely and compelling healthcare needs, blending technology innovation with sound business models built on a solid understanding of healthcare market incentives and constraints.” [...] Founded in 2019 by Dr Marta G. Zanchi, Nina Capital is set to build a new portfolio of investments across Europe, North America, Israel, and, for the first time, Australia with Fund III. From pre-Seed to Series A, the fund will write initial checks ranging from €250k to €1.5 million, with reserves to support portfolio companies through follow-on funding.